Loop Diuretics Increase Bone Turnover and Decrease BMD in Osteopenic Postmenopausal Women: Results From a Randomized Controlled Study With Bumetanide
Authors:
Open Access
- 1 January 2006
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 21 (1) , 163-170
Abstract
To study effects of loop diuretics on bone, 87 women were randomized to 1 year of treatment with bumetanide or placebo. Compared with placebo, bumetanide decreased BMD by 2% at the total hip and by 1.4% at the whole body. Levels of biochemical bone markers were lower in the placebo than in the bumetanide group. Thus, treatment with loop diuretics affects bone metabolism.Introduction: Loop diuretics may affect bone because they increase the renal calcium excretion and alters the diurnal rhythm of plasma PTH levels. We studied the effects of 1 year of treatment with the loop diuretic bumetanide on bone metabolism.Materials and Methods: In a double-blinded design, 87 healthy postmenopausal women with osteopenia were randomized to 1-year bumetanide treatment 2 mg/day or placebo. BMD, plasma levels of calcitropic hormones, and biochemical bone markers were measured at baseline, after 1 year of treatment (week 52), and 6 months after withdrawal of treatment (week 78). Calcium (800 mg/day) and vitamin D (10 μg/day) were administered to all participants during the entire 1.5-year study period.Results: Compared with placebo, urinary calcium (+17%) and plasma PTH levels (+9%) increased significantly in response to bumetanide. After 1 year of treatment, BMD in the bumetanide compared with the placebo group was significantly decreased by 2% at the total hip and ultradistal forearm and by 1.4% at the whole body. In addition, levels of biochemical markers of bone turnover differed significantly (∼20%) between groups, with lower levels in the placebo than in the bumetanide group. Six months after the end of treatment, the effects of bumetanide were weakening.Conclusions: Treatment with loop diuretics affects bone turnover and decreases BMD. Further studies may reveal whether loop diuretics should be considered as a risk factor for fracture.Keywords
This publication has 25 references indexed in Scilit:
- Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 2001
- Thiazide diuretics and fractures: Can meta-analysis help?Journal of Bone and Mineral Research, 1995
- Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly womenJournal of Bone and Mineral Research, 1993
- Thiazides and seasonal bone change in healthy postmenopausal womenBone and Mineral, 1993
- A specific immunoassay for monitoring human bone resorption: Quantitation of type I collagen cross-linked N-telopeptides in urineJournal of Bone and Mineral Research, 1992
- Role of drugs in fractures of the femoral neck.BMJ, 1986
- Thiazide Effect on the Mineral Content of BoneNew England Journal of Medicine, 1983
- Evidence for Secondary Hyperparathyroidism in Idiopathic HypercalciuriaJournal of Clinical Investigation, 1973
- EFFECT OF AGE ON CALCIUM ABSORPTIONThe Lancet, 1970
- TUBULAR REABSORPTION OF CALCIUM IN THE DIFFERENTIAL DIAGNOSIS OF HYPERCALCAEMIAActa Medica Scandinavica, 1970